Download our Mission Package
JDRF research focuses on key therapies that hold significant promise in turning Type One into Type None.
Recent Press Releases
- JDRF Commends Senators Collins and Shaheen for Introducing Legislation to Ensure Seniors with Diabetes Have Access to Continuous Glucose Monitors
- JDRF Presents 2014 Erwin Lurie Volunteer of the Year Award
- JDRF Announces 2014 National Volunteer Award Winner
- JDRF appoints Derek Rapp as new President & CEO
- JDRF Partner ViaCyte Announces Key Project Milestone to Advance Innovative Encapsulated Cell Replacement Therapy Product for Type 1 Diabetes
- Islet transplants aided type 1 diabetes patients
- Fighting diabetes one kick at a time
- Melbourne scientists make type 1 diabetes research breakthrough
- Do Closed-Loop Insulin Delivery Systems Improve Blood Glucose Control In Type 1 Diabetes?
- ViaCyte, Inc. Announces Signing of Rights Agreement with Janssen Research & Development LLC.
For all other inquiries, please contact JDRF Public Information.
Director, Public Relations
Office: (212) 479-7667